{"id":13285,"date":"2025-10-01T11:50:41","date_gmt":"2025-10-01T11:50:41","guid":{"rendered":"https:\/\/www.1stopasia.com\/blog\/?p=13285"},"modified":"2025-10-01T09:25:52","modified_gmt":"2025-10-01T09:25:52","slug":"pharma-localization-case-study","status":"publish","type":"post","link":"https:\/\/www.1stopasia.com\/blog\/pharma-localization-case-study\/","title":{"rendered":"Precision You Can Prescribe: Global Pharma Localization Case Study"},"content":{"rendered":"

AI Overview<\/h2>\n
\n\n\n\n\n\n\n\n\n
Category<\/strong><\/td>\nSummary<\/strong><\/td>\n<\/tr>\n
Topic<\/strong><\/td>\nSupporting Global Pharma with Compliant Multilingual Content<\/td>\n<\/tr>\n
Purpose<\/strong><\/td>\nTo demonstrate how 1-StopAsia helps leading pharmaceutical companies ensure compliance, security, and accuracy when localizing critical clinical trial and regulatory documentation.<\/td>\n<\/tr>\n
Key Insight<\/strong><\/td>\nIn pharmaceuticals, even small translation errors can delay trials, cause recalls, or risk patient safety. ISO\u2011certified workflows and subject\u2011matter experts guarantee precision and regulatory compliance.<\/td>\n<\/tr>\n
Best Use Case<\/strong><\/td>\nIdeal for pharma companies seeking a reliable localization partner to handle multilingual regulatory submissions, ICFs, SDSs, and training materials across global markets.<\/td>\n<\/tr>\n
Risk Warning<\/strong><\/td>\nInadequate or non\u2011compliant translations may lead to regulatory rejection, market delays, or severe legal and financial consequences.<\/td>\n<\/tr>\n
Pro Tip<\/strong><\/td>\nChoose a localization partner with ISO certifications (9001, 17100, 18587, 27001) and proven expertise in pharma to streamline approvals and safeguard patient safety.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n
Download Article<\/a><\/div>\n
<\/div>\n<\/div>\n

Client Profile<\/h2>\n

A leading multinational pharmaceutical company preparing regulatory submissions and multilingual clinical trial documentation for simultaneous market entry across North America, Europe, and Asia.<\/p>\n

They needed a localization partner able to manage highly sensitive content under strict regulatory oversight \u2014 from informed consent forms (ICFs) and drug labeling to internal training manuals for MSLs and field reps.<\/p>\n

Industry:<\/strong> Pharmaceuticals<\/p>\n

The Challenge<\/h2>\n

In pharmaceuticals, localization errors aren\u2019t just costly \u2014 they can be life-threatening.<\/p>\n

This client required a trusted partner to ensure:<\/p>\n

    \n
  • Regulatory precision<\/strong> for content aligned with FDA, EMA, and PMDA requirements.<\/li>\n
  • Fast multilingual rollout<\/strong> of clinical trial materials, including investigator brochures and ICFs, within aggressive timelines.<\/li>\n
  • Consistent formatting<\/strong> across complex document types \u2014 SDSs, drug labels, prescribing information \u2014 in 15+ languages.<\/li>\n
  • Strict information security<\/strong> for unpublished research, trial data, and pre-market communications.<\/li>\n
  • Agile project management<\/strong> to accommodate last-minute edits, file conversions, and country-specific updates.<\/li>\n<\/ul>\n

    The Solution<\/h2>\n

    1-StopAsia built a customized localization workflow<\/strong> designed for every stage of the pharmaceutical lifecycle:<\/p>\n

      \n
    • ISO 9001 & 17100-Certified Processes<\/strong> for critical materials such as clinical documentation, SmPCs, and regulatory submissions.<\/li>\n
    • ISO 18587-Compliant Post-Editing<\/strong> of MT output, used selectively for internal references to save time and cost.<\/li>\n
    • ISO 27001-Certified Data Security<\/strong> to safeguard sensitive data, from trial protocols to training content.<\/li>\n
    • Multilingual DTP<\/strong> ensuring all labels and layouts meet both local and global compliance standards.<\/li>\n
    • Regulatory-aware linguists<\/strong> with pharma subject-matter expertise to guarantee terminology consistency and cultural accuracy.<\/li>\n
    • Flexible project teams<\/strong> integrating seamlessly into the client\u2019s review cycles, regulatory calendars, and submission systems.<\/li>\n<\/ul>\n

      The Results<\/h2>\n

      Partnering with 1-StopAsia enabled the client to:
      \n\"ISO-certified<\/p>\n

        \n
      • Submit ICFs and regulatory documents in 18 languages<\/strong> for simultaneous EMA and FDA approvals.<\/li>\n
      • Reduce document turnaround times by 30%<\/strong> through pre-approved terminology banks and review-ready formats.<\/li>\n
      • Standardize SDS translation workflows to minimize audit risks.<\/li>\n
      • Localize MSL training manuals and sales enablement materials for 22 markets<\/strong> while maintaining compliance and brand tone.<\/li>\n<\/ul>\n

        These results allowed the client\u2019s regulatory, marketing, and clinical teams to operate in sync<\/strong> \u2014 without translation bottlenecks.<\/p>\n

        Certifications & Trust Signals<\/h2>\n

        Certified to meet the highest standards in pharma:<\/p>\n

        \u2705 ISO 9001 \u2013 Quality Management Systems
        \n\u2705 ISO 17100 \u2013 Translation Services
        \n\u2705 ISO 18587 \u2013 Post-Editing of Machine Translation Output
        \n\u2705 ISO 27001 \u2013 Information Security Management Systems<\/p>\n

        “When precision, compliance, and responsiveness are non-negotiable, pharmaceutical leaders trust 1-StopAsia to deliver multilingual content that\u2019s audit-ready and regulator-proof.”<\/i><\/p>\n

        Why It Matters<\/h2>\n

        In pharma, a single mistranslation can delay a trial, trigger a recall, or endanger patient safety.
        \nWith ISO-certified processes and expert linguists, 1-StopAsia delivers not just translations \u2014 but true localization partnerships<\/strong> that ensure safe, accurate, and compliant communication on a global scale.<\/p>\n